All Insights
Showing 1 - 12 of 406
Intellectual property
UK government launches call for evidence on feasibility of UKIPO-led FRAND opinion service
Indications given about scope of the potential FRAND opinion service, while guidance sought from stakeholders on its workability and design
Life Sciences and Healthcare
EU pharma package widens the Bolar exemption and moves the line on patent infringement
Pricing and reimbursement procedures, tender bids and third-party suppliers will fall outside patent infringement. Originators lose an important hook for
Intellectual property
English High Court strengthens online platforms' position as Shein's copyright claims dismissed
Temu not liable for primary or secondary infringement over product listing photos uploaded by third-party sellers
Data Centres
Data centre developers and investors face growing patent litigation risk in the UK and Europe
Patent disputes are moving from the margins to the heart of project risk: a shift the industry is starting to
Intellectual property
UK government rows back on SEP licensing reforms following consultation
A rate-setting court track and injunction reforms are abandoned as government opts for targeted, guidance-led measures
Life Sciences and Healthcare
UK life sciences head into autumn as policy and regulatory reforms race to match tech advances
MHRA progresses on AI, gene therapy and medicines regulation as the UK positions itself as a global sector leader
Regulatory and compliance
EU clamps down on meat names for plant-based and cultivated alternatives
New rules for the use of meat terms will force plant-based and cultivated producers to rebrand ahead of a 2029
Life Sciences and Healthcare
English High Court grants dynamic website blocking order to tackle counterfeit medicines
Creative solution to IP and regulatory breaches gives life sciences companies greater control over unlawful online sales
Dispute resolution
English Court of Appeal considers meaning of 'public domain' in confidentiality dispute
Information shared with around 200 potential investors may constitute confidential information under an NDA
Life Sciences and Healthcare
European courts and regulators target the intersection of regulatory and patent trends in the life sciences
The Tecfidera case and provisional pharma reform agreement put regulatory exclusivity and patent protection in focus
Unified Patent Court
UPC's Düsseldorf Local Division gives guidance on infringement by equivalents
Düsseldorf has adopted The Hague Local Division's Plant-e test and offered guidance on its application
